Use of CD40L immunoconjugates to overcome the defective immune response to vaccines for infections and cancer in the aged.
about
The early autophagic pathway is activated by hepatitis B virus and required for viral DNA replication.CD154 expression is associated with neutralizing antibody titer levels postinfluenza vaccination in stem cell transplant patients and healthy adultsCD40 is required for protective immunity against liver stage Plasmodium infectionCD40 ligand enhances immunogenicity of vector-based vaccines in immunocompetent and CD4+ T cell deficient individuals.Dendritic cell activation and memory cell development are impaired among mice administered medroxyprogesterone acetate prior to mucosal herpes simplex virus type 1 infectionTAA/ecdCD40L adenoviral prime-protein boost vaccine for cancer and infectious diseases.Considerations for successful cancer immunotherapy in aged hosts.Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout.Aging and lymphocyte changes by immunomodulatory therapies impact PML risk in multiple sclerosis patients.
P2860
Q33732897-7FF8FEB4-BF20-4355-B915-CE8280E20134Q34104346-5C134402-74FE-47E5-A03A-DF0B00F55EBAQ35122368-73493CBC-7415-4078-898D-5F0920D554B9Q35854792-863E74DC-B754-4C25-93A5-F3DFB70BFD02Q36252465-81209D12-A488-482A-B4F1-A515FA417F3CQ38067267-6A8BFEB8-1223-4AFC-A92C-43027A8E0F5EQ38815953-6D8F0273-6502-4745-B887-8A121C1108F7Q40793204-54238589-B8A5-4E07-B151-DD43859E6681Q54207057-56CCEB9F-99F0-4B6D-9512-45EB1A97A00A
P2860
Use of CD40L immunoconjugates to overcome the defective immune response to vaccines for infections and cancer in the aged.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Use of CD40L immunoconjugates ...... ctions and cancer in the aged.
@en
Use of CD40L immunoconjugates ...... ctions and cancer in the aged.
@nl
type
label
Use of CD40L immunoconjugates ...... ctions and cancer in the aged.
@en
Use of CD40L immunoconjugates ...... ctions and cancer in the aged.
@nl
prefLabel
Use of CD40L immunoconjugates ...... ctions and cancer in the aged.
@en
Use of CD40L immunoconjugates ...... ctions and cancer in the aged.
@nl
P2093
P2860
P1476
Use of CD40L immunoconjugates ...... ctions and cancer in the aged.
@en
P2093
Albert Deisseroth
Marilyn Thoman
Phyllis-Jean Linton
Yu Cheng Tang
P2860
P2888
P304
P356
10.1007/S00262-009-0718-3
P577
2009-05-15T00:00:00Z